Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for proto oncogene proteins
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Induced pluripotent stem cells by direct delivery of Oct4, Sox2, Klf4,and c-Myc proteins
Most Relevant Literature
- Acute myeloblastic leukaemia with alternations of MLL proto-oncogene protein (11q23/MLL+ AML)].
- Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7).
- Molecular biological diagnostics of KRAS and BRAF mutations in patients with colorectal cancer - lab…
- Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways.
- Response to Li and Su letter.
Most Relevant Clinical Trials
- A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcript…
- Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and …
- To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healt…
- Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
- ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological Features
